What is Collegium Pharmaceutical Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Collegium Pharmaceutical's Average Total Inventories for the quarter that ended in Mar. 2024 was $31.8 Mil. Collegium Pharmaceutical's Revenue for the
three
months ended in Mar. 2024 was $144.9 Mil.
Collegium Pharmaceutical's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.22.
Collegium Pharmaceutical's Inventory-to-Revenue for the quarter that ended in Mar. 2024
declined
from Dec. 2023 (0.22) to Dec. 2023 (0.22)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Collegium Pharmaceutical's Days Inventory for the
three
months ended in Mar. 2024 was 54.28.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Collegium Pharmaceutical's Inventory Turnover for the quarter that ended in Mar. 2024 was 1.68.
Collegium Pharmaceutical Inventory-to-Revenue Historical Data
The historical data trend for Collegium Pharmaceutical's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Collegium Pharmaceutical Inventory-to-Revenue Chart
Competitive Comparison of Collegium Pharmaceutical's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Collegium Pharmaceutical's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Collegium Pharmaceutical's Inventory-to-Revenue falls into.
Collegium Pharmaceutical Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Collegium Pharmaceutical's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Collegium Pharmaceutical (NAS:COLL) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Collegium Pharmaceutical's Days Inventory for the
three
months ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Collegium Pharmaceutical Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Collegium Pharmaceutical's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Collegium Pharmaceutical (Collegium Pharmaceutical) Business Description
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COLL has been successfully added to your 